How much did Lucy Therapeutics, Inc. raise?

Lucy Therapeutics, Inc. raised $15 Million in a funding round on January 6, 2022.

Who are the decision-makers at Lucy Therapeutics, Inc?

Fundz holds 1 contact at Lucy Therapeutics, Inc., including the Director. Names and contact details are shown to Fundz members.

Lucy Therapeutics, Inc. reported raising $15 Million in an initial SEC Form D filing, from an offering of $20 Million

PRIVATEJan 06, 2022$15M of $20M raised

Amount Raised

$15 Million

$15 Million sold, per SEC Form D (first sale Jan 6, 2022)

Round Type

Venture

WalthamHealthcareBiotechnology Research

Quick answer

Lucy Therapeutics, Inc. raised $15 Million in a funding round, dated January 6, 2022. Lucy Therapeutics, Inc. is based in Waltham, Massachusetts, United States.

How much did Lucy Therapeutics, Inc. raise?: Lucy Therapeutics, Inc. raised $15 Million in a funding round on January 6, 2022.
What does Lucy Therapeutics, Inc. do?: Lucy Therapeutics is offering a differentiated and novel approach to drug discovery by drugging targets associated with early disease pathogenesis.
Where is Lucy Therapeutics, Inc. based and how big is it?: Lucy Therapeutics, Inc. is based in Waltham, Massachusetts, United States.
Who are the decision-makers at Lucy Therapeutics, Inc?: Fundz holds 1 contact at Lucy Therapeutics, Inc., including the Director. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare and Biotechnology Research around the same time

Companies in the same sectors as Lucy Therapeutics, Inc. that raised within 45 days of this round, from Fundz verified event records.

SOMAVAC Medical Solutions, Inc. raised an undisclosed amount on December 14, 2021.
SOMAVAC Medical Solutions, Inc. raised $970K on December 3, 2021.
The Cannabist Company Holdings raised $75M on February 18, 2022.
Earlitec Diagnostics raised $5.5M on February 18, 2022.
Earlitec Diagnostics raised $20M (Funding Round) on February 18, 2022.
NEUROGAMI MEDICAL, INC. raised $1.8M (Seed) on February 18, 2022.

Who to call at Lucy Therapeutics, Inc., and when

A new round usually means Lucy Therapeutics, Inc. is about to hire and buy. The teams that reach out first get the meeting.

An alert the day Lucy Therapeutics, Inc. raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Lucy Therapeutics, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Lucy Therapeutics, Inc.. With Fundz connected, it knows.

Watch Fundz in

See plan options

Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Lucy Therapeutics, Inc.

Location

21 Hickory Drive, Suite 2B

Waltham, Massachusetts, United States

About

Lucy Therapeutics is offering a differentiated and novel approach to drug discovery by drugging targets associated with early disease pathogenesis. LucyTx’s unique approach recognizes that improvement of mitochondrial function early in disease will lead to disease modification as opposed to late-stage symptomatic treatments being pursued by many others. Mitochondrial improvement effects multiple downstream effectors that are essential to disease initiation and progression. Our targets have been validated as neuroprotective in multiple animal models. Key to our strategy is a novel dosing regimen which will mimic effects known to be protective for both neurological and cardiovascular events implicated in key CNS diseases. LucyTx proposes to focus on the orphan disease Rett Syndrome for a proof of concept; we will also explore applications of our technology to Parkinson’s and other CNS diseases.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Lucy Therapeutics, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Book a demo Explore plans

Related People

1 contact

Verified contactsAmy R., Director hiddenSee plans and pricing

Predictive Intelligence

Strategic

ML-powered predictions for Lucy Therapeutics, Inc.'s next move

See what Strategic adds

Lucy Therapeutics, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

Show me how a sales rep uses this Or see plans and pricing →

5 screens from a live account. No signup.